Is CBD classified as a medicine?

Cannabidiol (CBD) has become much more widely known in recent years. In

Switzerland, many people are interested in products made from the hemp plant – such as

oils, flowers or vapes.

This often raises a central question:

Is CBD classified as a medicine – or is it a freely

available product?

The answer depends on the type of product, its intended purpose and its

legal classification.

What is cannabidiol (CBD)?

CBD is a naturally occurring component of the hemp plant (Cannabis sativa L.).

Unlike THC (tetrahydrocannabinol), CBD has no psychoactive effect

and does not cause intoxication.

CBD interacts with the so-called endocannabinoid system (ECS), a

regulatory system of the body itself. In scientific

literature, this system is discussed in connection with various physiological processes.

Important:

CBD is not a medicinal product per se. Its classification depends on the specific product and

its approval.

When is a product considered a medicine?

In Switzerland, classification as a medicinal product is governed by the Therapeutic Products Act (HMG).

A product is classified as a medicine if it:

• is intended to treat or prevent diseases
• claims a therapeutic effect
• has been clinically tested
• is approved by Swissmedic

Such products may only be sold under certain conditions – often

on prescription or through pharmacies.

Why freely available CBD products are not medicines

Most CBD products on the Swiss market – including CBD oils, CBD flower or

CBD vapes – are not approved medicinal products.

They are classified differently under the law, for example as:

• cosmetic product
• raw material product
• aroma or fragrance product
• technical product

What matters is:

These products must not make any medical healing claims.

Reputable suppliers therefore deliberately avoid statements such as “heals”, “treats” or

“works against disease X”.

At Vaporspirit.ch, too, CBD products are not promoted as medicines;

instead, they are offered transparently as natural products with a clearly declared

composition.

Exception: approved CBD medicines

There is one approved CBD medicine in Switzerland:

Epidyolex®

This preparation contains purified cannabidiol and is medically approved for certain rare

forms of epilepsy.

Such approval requires extensive clinical studies, safety evidence

and regulatory review procedures. It is dispensed exclusively under

medical supervision.

These strictly regulated medicines are not comparable with freely available CBD

products.

CBD in Switzerland: legal classification

In Switzerland, the following applies:

CBD products are legal provided the THC content is below 1 %.

This means they do not fall under the Narcotics Act.

Compliance with these limits is checked by competent authorities such as:

• Swissmedic
• Federal Office of Public Health (BAG)

which are responsible for this monitoring.

Products that are wrongly advertised with medical claims of effectiveness

may violate the Therapeutic Products Act.

Research on CBD

CBD is being studied scientifically worldwide. Studies look, among

other things, at:

• neurological questions
• inflammation-related processes
• regulatory mechanisms in the endocannabinoid system

Many of these investigations are still at the research or

preclinical stage.

What matters is a clear distinction between:

• scientific research
• approved medicinal product
• freely available product

Freely available CBD products are not medically approved therapies.

Difference between a medicine and freely available CBD

Conclusion: is CBD classified as a medicine?

The answer is:

No – in Switzerland, freely available CBD products are not

classified as medicines.

Only specially approved preparations such as Epidyolex® count as medicinal products.

Commercially available CBD products – such as oils or flowers – are legally not

medicines as long as:

• the THC content is below 1 %
• no medical claims of effectiveness are made
• the legal requirements are met

Transparency and quality

If you buy CBD products, you should pay attention to the following points:

• transparent laboratory analyses
• clear THC declaration
• traceable origin
• reputable communication from the supplier

According to its own information, Vaporspirit.ch relies on Swiss raw materials, controlled

production and clear product declaration – without medical healing claims.

Frequently asked questions about the classification of CBD

Is CBD a medicine in Switzerland?

No. Freely available CBD products are not considered medicines in Switzerland.

Only specially approved preparations with Swissmedic approval are classified as medicinal

products.

When is a CBD product considered a medicinal product?

A product is considered a medicinal product if it claims a therapeutic effect,

has been clinically tested and is approved by Swissmedic.

May CBD be advertised with healing claims?

No. Freely available CBD products must not be advertised with statements such as “heals” or

“treats diseases”. Such statements would only be permitted for

approved medicinal products.

Is CBD legal in Switzerland?

Yes. CBD products are legal in Switzerland as long as the THC content is below 1 %

and the legal requirements are met.

Are there approved CBD medicines?

Yes. There are approved CBD-based medicinal products that may only be used under

medical supervision. These are not comparable with freely available

products.

Note

This article is for general information only and does not constitute

medical advice. Cannabidiol (CBD) is not a medicinal product. No

healing or health claims are made.

Legal notice (Switzerland)

CBD products are legal in Switzerland provided the THC content is below 1 % and the

applicable legal requirements are met.

The content refers exclusively to the legal situation in Switzerland.

Disclaimer

If you have health complaints, you should always consult a medical

professional.